The GBS-CIDP Foundation International has designated M Health Fairview as a “Center of Excellence” for the diagnosis and treatment of Guillain-Barré Syndrome and CIDP.  We also specialize in the related autoimmune neuropathies Multifocal Motor Neuropathy (MMN) and anti-MAG polyneuropathy.

Like many rare diseases, CIDP, GBS, and related neuropathies can be challenging to diagnosis and treat. Our diagnostic approach is to use a litany of tools to arrive at an expeditious and accurate diagnosis. At our disposal includes laboratory services, genetic testing, nerve conduction studies/EMG, imaging (MRI and ultrasound), skin biopsy, and nerve and muscle biopsy. Our treatment approach is rooted in evidence based treatment guidelines, but also is careful to take into account the uniqueness of each individual person.

When needed, we have access to a multidisciplinary team of specialist that may include physical therapist, social workers, and pain management specialist to round out the treatment approach. M Health Fairview frequently participates in CIDP and GBS clinical trials. Interested patients have access to clinicians with knowledge on the latest in CIDP and GBS research, from ongoing clinical trials to innovations in early development.